Tetraspanin 3 Is Required for the Development and Propagation of Acute Myelogenous Leukemia

Cell Stem Cell

Volumn 17, Issue 2, 2015, Pages 152-164

  Kwon, Hyog Young ^a,b   Bajaj, Jeevisha ^a,c   Ito, Takahiro ^a,c   Blevins, Allen ^a,c   Konuma, Takaaki ^a,c   Weeks, Joi ^a,c   Lytle, Nikki K ^a,c   Koechlein, Claire S ^a,c   Rizzieri, David ^d   Chuah, Charles ^e   Oehler, Vivian G ^f   Sasik, Roman ^a   Hardiman, Gary ^a,g,i   Reya, Tannishtha ^a,c,d,h  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Soonchunhyang University   (South Korea)

^c Sanford Consortium for Regenerative Medicine   (United States)

^d DUKE UNIVERSITY   (United States)

^e SINGAPORE GENERAL HOSPITAL   (Singapore)

^f USA   (United States)

^g SAN DIEGO STATE UNIVERSITY   (United States)

^h UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

ⁱ MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; BCL2 RELATED PROTEIN A1; BROXURIDINE; CD135 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; MEMBRANE PROTEIN; MUSASHI 2 PROTEIN; PROTEIN BID; RNA BINDING PROTEIN; SHORT HAIRPIN RNA; STROMAL CELL DERIVED FACTOR 1; TETRASPANIN 3; TRANSCRIPTION FACTOR SOX4; UNCLASSIFIED DRUG; HISTONE LYSINE METHYLTRANSFERASE; MIXED LINEAGE LEUKEMIA PROTEIN; MLL PROTEIN, MOUSE; TETRASPANIN; TSPAN3 PROTEIN, HUMAN; TSPAN3 PROTEIN, MOUSE;

ACUTE MYELOBLASTIC LEUKEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BLAST CELL CRISIS; CANCER LOCALIZATION; CARCINOGENESIS; CELL DIFFERENTIATION; CELL FUNCTION; CELL MIGRATION; CELL RENEWAL; COLONY FORMATION; COLONY FORMING UNIT; CONTROLLED STUDY; GENE DELETION; GENE EXPRESSION; GENETIC ASSOCIATION; HEMATOPOIETIC STEM CELL; LEUKEMOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SENESCENCE; STEM CELL; WILD TYPE; ACUTE MYELOID LEUKEMIA; ANIMAL; C57BL MOUSE; CANCER STEM CELL; CELL MOTION; CHRONIC MYELOID LEUKEMIA; DEFICIENCY; DRUG EFFECTS; DRUG SCREENING; GENETICS; GENOME; HUMAN; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY;

MUS;

ANIMALS; CARCINOGENESIS; CELL MOVEMENT; CHEMOKINE CXCL12; GENOME; HISTONE-LYSINE N-METHYLTRANSFERASE; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; LEUKEMIA, MYELOID, ACUTE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOID-LYMPHOID LEUKEMIA PROTEIN; NEOPLASTIC STEM CELLS; TETRASPANINS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84938741455     PISSN: 19345909     EISSN: 18759777     Source Type: Journal    
DOI: 10.1016/j.stem.2015.06.006     Document Type: Article

References (44)

1. C. Boucheix, G.H. Duc, C. Jasmin, and E. Rubinstein Tetraspanins and malignancy Expert Rev. Mol. Med. 2001 2001 1 17
2. R.J. Byers, T. Currie, E. Tholouli, S.J. Rodig, and J.L. Kutok MSI2 protein expression predicts unfavorable outcome in acute myeloid leukemia Blood 118 2011 2857 2867
3. Y. Chen, J. Cortes, Z. Estrov, S. Faderl, W. Qiao, L. Abruzzo, G. Garcia-Manero, S. Pierce, X. Huang, P. Kebriaei, and et al. Persistence of cytogenetic abnormalities at complete remission after induction in patients with acute myeloid leukemia: prognostic significance and the potential role of allogeneic stem-cell transplantation J. Clin. Oncol. 29 2011 2507 2513
4. Y. Chen, R. Jacamo, M. Konopleva, R. Garzon, C. Croce, and M. Andreeff CXCR4 downregulation of let-7a drives chemoresistance in acute myeloid leukemia J. Clin. Invest. 123 2013 2395 2407
5. A. Colmone, M. Amorim, A.L. Pontier, S. Wang, E. Jablonski, and D.A. Sipkins Leukemic cells create bone marrow niches that disrupt the behavior of normal hematopoietic progenitor cells Science 322 2008 1861 1865
6. R. de Sousa Abreu, P.C. Sanchez-Diaz, C. Vogel, S.C. Burns, D. Ko, T.L. Burton, D.T. Vo, S. Chennasamudaram, S.Y. Le, B.A. Shapiro, and L.O. Penalva Genomic analyses of musashi1 downstream targets show a strong association with cancer-related processes J. Biol. Chem. 284 2009 12125 12135
7. J. Faber, A.V. Krivtsov, M.C. Stubbs, R. Wright, T.N. Davis, M. van den Heuvel-Eibrink, C.M. Zwaan, A.L. Kung, and S.A. Armstrong HOXA9 is required for survival in human MLL-rearranged acute leukemias Blood 113 2009 2375 2385
8. H.F. Fernandez, Z. Sun, X. Yao, M.R. Litzow, S.M. Luger, E.M. Paietta, J. Racevskis, G.W. Dewald, R.P. Ketterling, J.M. Bennett, and et al. Anthracycline dose intensification in acute myeloid leukemia N. Engl. J. Med. 361 2009 1249 1259
9. A. Garcia-España, P.J. Chung, I.N. Sarkar, E. Stiner, T.T. Sun, and R. Desalle Appearance of new tetraspanin genes during vertebrate evolution Genomics 91 2008 326 334
10. M.E. Hemler Tetraspanin functions and associated microdomains Nat. Rev. Mol. Cell Biol. 6 2005 801 811
11. M.E. Hemler, B.A. Mannion, and F. Berditchevski Association of TM4SF proteins with integrins: relevance to cancer Biochim. Biophys. Acta 1287 1996 67 71
12. T. Ito, H.Y. Kwon, B. Zimdahl, K.L. Congdon, J. Blum, W.E. Lento, C. Zhao, A. Lagoo, G. Gerrard, L. Foroni, and et al. Regulation of myeloid leukaemia by the cell-fate determinant Musashi Nature 466 2010 765 768
13. S.A. Jankowski, D.S. Mitchell, S.H. Smith, J.M. Trent, and P.S. Meltzer SAS, a gene amplified in human sarcomas, encodes a new member of the transmembrane 4 superfamily of proteins Oncogene 9 1994 1205 1211
14. M.G. Kharas, C.J. Lengner, F. Al-Shahrour, L. Bullinger, B. Ball, S. Zaidi, K. Morgan, W. Tam, M. Paktinat, R. Okabe, and et al. Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemia Nat. Med. 16 2010 903 908
15. Y. Klipper-Aurbach, M. Wasserman, N. Braunspiegel-Weintrob, D. Borstein, S. Peleg, S. Assa, M. Karp, Y. Benjamini, Y. Hochberg, and Z. Laron Mathematical formulae for the prediction of the residual beta cell function during the first two years of disease in children and adolescents with insulin-dependent diabetes mellitus Med. Hypotheses 45 1995 486 490
16. A.V. Krivtsov, and S.A. Armstrong MLL translocations, histone modifications and leukaemia stem-cell development Nat. Rev. Cancer 7 2007 823 833
17. J. Lessard, and G. Sauvageau Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells Nature 423 2003 255 260
18. Z. Li, Z. Zhang, Y. Li, S. Arnovitz, P. Chen, H. Huang, X. Jiang, G.M. Hong, R.B. Kunjamma, H. Ren, and et al. PBX3 is an important cofactor of HOXA9 in leukemogenesis Blood 121 2013 1422 1431
19. A.C. Moss, P.P. Doran, and P. Macmathuna In Silico Promoter Analysis can Predict Genes of Functional Relevance in Cell Proliferation: Validation in a Colon Cancer Model Transl. Oncogenomics 2 2007 1 16
20. B. Nervi, P. Ramirez, M.P. Rettig, G.L. Uy, M.S. Holt, J.K. Ritchey, J.L. Prior, D. Piwnica-Worms, G. Bridger, T.J. Ley, and J.F. DiPersio Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100 Blood 113 2009 6206 6214
21. G. Paxinos, and K.B.J. Franklin Paxinos and Franklin's the Mouse Brain in Stereotaxic Coordinates, Fourth Edition 2012 Academic Press
22. T. Robak Application of new drugs in chronic lymphocytic leukemia Mediterr. J. Hematol. Infect. Dis. 2 2010 e2010011
23. T. Robak, P. Robak, and P. Smolewski TRU-016, a humanized anti-CD37 IgG fusion protein for the potential treatment of B-cell malignancies Curr. Opin. Invest. Drugs 10 2009 1383 1390
24. G.J. Roboz Current treatment of acute myeloid leukemia Curr. Opin. Oncol. 24 2012 711 719
25. E.J. Rombouts, B. Pavic, B. Löwenberg, and R.E. Ploemacher Relation between CXCR-4 expression, Flt3 mutations, and unfavorable prognosis of adult acute myeloid leukemia Blood 104 2004 550 557
26. R. Sasik, C.H. Woelk, and J. Corbeil Microarray truths and consequences J. Mol. Endocrinol. 33 2004 1 9
27. J.L. Shipley, and J.N. Butera Acute myelogenous leukemia Exp. Hematol. 37 2009 649 658
28. D.A. Sipkins, X. Wei, J.W. Wu, J.M. Runnels, D. Côté, T.K. Means, A.D. Luster, D.T. Scadden, and C.P. Lin In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment Nature 435 2005 969 973
29. E.A. Sison, E. McIntyre, D. Magoon, and P. Brown Dynamic chemotherapy-induced upregulation of CXCR4 expression: a mechanism of therapeutic resistance in pediatric AML Mol. Cancer Res. 11 2013 1004 1016
30. A.C. Spoo, M. Lübbert, W.G. Wierda, and J.A. Burger CXCR4 is a prognostic marker in acute myelogenous leukemia Blood 109 2007 786 791
31. A. Subramanian, P. Tamayo, V.K. Mootha, S. Mukherjee, B.L. Ebert, M.A. Gillette, A. Paulovich, S.L. Pomeroy, T.R. Golub, E.S. Lander, and J.P. Mesirov Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles Proc. Natl. Acad. Sci. USA 102 2005 15545 15550
32. S.M. Sykes, S.W. Lane, L. Bullinger, D. Kalaitzidis, R. Yusuf, B. Saez, F. Ferraro, F. Mercier, H. Singh, K.M. Brumme, and et al. AKT/FOXO signaling enforces reversible differentiation blockade in myeloid leukemias Cell 146 2011 697 708
33. S. Szala, Y. Kasai, Z. Steplewski, U. Rodeck, H. Koprowski, and A.J. Linnenbach Molecular cloning of cDNA for the human tumor-associated antigen CO-029 and identification of related transmembrane antigens Proc. Natl. Acad. Sci. USA 87 1990 6833 6837
34. S. Tavor, I. Petit, S. Porozov, A. Avigdor, A. Dar, L. Leider-Trejo, N. Shemtov, V. Deutsch, E. Naparstek, A. Nagler, and T. Lapidot CXCR4 regulates migration and development of human acute myelogenous leukemia stem cells in transplanted NOD/SCID mice Cancer Res. 64 2004 2817 2824
35. S. Tavor, M. Eisenbach, J. Jacob-Hirsch, T. Golan, I. Petit, K. Benzion, S. Kay, S. Baron, N. Amariglio, V. Deutsch, and et al. The CXCR4 antagonist AMD3100 impairs survival of human AML cells and induces their differentiation. Leukemia: official journal of the Leukemia Society of America Leukemia 22 2008 2151 5158
36. S.K. Tiwari-Woodruff, A.G. Buznikov, T.Q. Vu, P.E. Micevych, K. Chen, H.I. Kornblum, and J.M. Bronstein OSP/claudin-11 forms a complex with a novel member of the tetraspanin super family and beta1 integrin and regulates proliferation and migration of oligodendrocytes J. Cell Biol. 153 2001 295 305
37. V.G. Tusher, R. Tibshirani, and G. Chu Significance analysis of microarrays applied to the ionizing radiation response Proc. Natl. Acad. Sci. USA 98 2001 5116 5121
38. G.L. Uy, M.P. Rettig, I.H. Motabi, K. McFarland, K.M. Trinkaus, L.M. Hladnik, S. Kulkarni, C.N. Abboud, A.F. Cashen, K.E. Stockerl-Goldstein, and et al. A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia Blood 119 2012 3917 3924
39. Y. Wang, A.V. Krivtsov, A.U. Sinha, T.E. North, W. Goessling, Z. Feng, L.I. Zon, and S.A. Armstrong The Wnt/beta-catenin pathway is required for the development of leukemia stem cells in AML Science 327 2010 1650 1653
40. M.D. Wright, G.W. Moseley, and A.B. van Spriel Tetraspanin microdomains in immune cell signalling and malignant disease Tissue Antigens 64 2004 533 542
41. T. Yagi, A. Morimoto, M. Eguchi, S. Hibi, M. Sako, E. Ishii, S. Mizutani, S. Imashuku, M. Ohki, and H. Ichikawa Identification of a gene expression signature associated with pediatric AML prognosis Blood 102 2003 1849 1856
42. B.B. Zeisig, A.G. Kulasekararaj, G.J. Mufti, and C.W. So SnapShot: acute myeloid leukemia Cancer Cell 22 2012 698-698
43. Z. Zeng, Y.X. Shi, I.J. Samudio, R.Y. Wang, X. Ling, O. Frolova, M. Levis, J.B. Rubin, R.R. Negrin, E.H. Estey, and et al. Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML Blood 113 2009 6215 6224
44. B. Zimdahl, T. Ito, A. Blevins, J. Bajaj, T. Konuma, J. Weeks, C.S. Koechlein, H.Y. Kwon, O. Arami, D. Rizzieri, and et al. Lis1 regulates asymmetric division in hematopoietic stem cells and in leukemia Nat. Genet. 46 2014 245 252